This proposal is for the establishment of a Specialized Center of Research in Hematopoietic Stem Cell (HSC) Biology at the Childrens Hospital Los Angeles (CHLA). The programmatic focus of the grant is the isolation and genetic modification of HSC for the purpose of improving the treatment of patients with hematological, genetic and immunological diseases. The grant is multi-disciplinary in nature with investigators from CHLA, the UCLA School of Medicine and the USC School of Medicine and contains research in the areas of HSC isolation, HSC differentiation, clinical bone marrow transplantation (BMT), hematopoietic and lymphoid growth factors, immunology, gene transduction and clinical gene therapy. The proposal contains four Projects and four Cores, including an Administrative Core that contains two pilot projects by junior investigators. The Scientific Aims include 1) the role of homeobox genes in the regulation of HSC differentiation; 2) the evaluation of HSC gene transduction in an in vivo xenogeneic bnx/hu mouse model; 3) the determination of the role of growth factors [IL-7, stem cell factor (SCF)] in T lymphopoiesis; 4) the determination of the in vivo repopulating capacity of high purified human HSC (CD34+, CD38-cells); and 5) clinical gene therapy trials for adenosine deaminase (ADA) deficiency and Gaucher disease. The SCOR will support a monthly seminar series and a bi- annual Gene Therapy Symposium. Overall the application is an attempt to integrate basic research, pre-clinical investigation and clinical protocols with the ultimate goal of improving therapy for patients with hematological, genetic and immunological diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL054850-04
Application #
2771450
Study Section
Special Emphasis Panel (ZHL1-CSR-K (S1))
Project Start
1995-09-30
Project End
2000-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
094878337
City
Los Angeles
State
CA
Country
United States
Zip Code
90027
Candotti, Fabio; Shaw, Kit L; Muul, Linda et al. (2012) Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood 120:3635-46
Rappeport, Joel M; O'Reilly, Richard J; Kapoor, Neena et al. (2010) Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us. Immunol Allergy Clin North Am 30:17-30
Bauer, Gerhard; Dao, Mo A; Case, Scott S et al. (2008) In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Mol Ther 16:1308-15
Dao, Mo A; Nolta, Jan A (2007) Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. Blood 109:2373-9
Engel, Barbara C; Podsakoff, Greg M; Ireland, Joanna L et al. (2007) Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Blood 109:503-6
Hollis, Roger P; Nightingale, Sarah J; Wang, Xiuli et al. (2006) Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon. Exp Hematol 34:1333-43
Hess, David A; Wirthlin, Louisa; Craft, Timothy P et al. (2006) Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107:2162-9
Montecino-Rodriguez, Encarnacion; Leathers, Hyosuk; Dorshkind, Kenneth (2006) Identification of a B-1 B cell-specified progenitor. Nat Immunol 7:293-301
Buckley, S; Barsky, L; Weinberg, K et al. (2005) In vivo inosine protects alveolar epithelial type 2 cells against hyperoxia-induced DNA damage through MAP kinase signaling. Am J Physiol Lung Cell Mol Physiol 288:L569-75
Podsakoff, Greg M; Engel, Barbara C; Carbonaro, Denise A et al. (2005) Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells. Mol Ther 12:77-86

Showing the most recent 10 out of 55 publications